According to Chembio Diagnostics's latest financial reports and stock price the company's current Operating Margin is -91.98%. At the end of 2021 the company had an Operating Margin of -91.98%.
Year | Operating Margin | Change |
---|---|---|
2021 | -91.98% | 7.82% |
2020 | -85.31% | 107.41% |
2019 | -41.13% | 73.22% |
2018 | -23.75% | -11.73% |
2017 | -26.90% | -36.3% |
2016 | -42.23% | 187.96% |
2015 | -14.67% | 161.56% |
2014 | -5.61% | -262.8% |
2013 | 3.44% | -39.19% |
2012 | 5.66% | 2.09% |
2011 | 5.55% | -63.79% |
2010 | 15.32% | 585.76% |
2009 | 2.23% | -112.67% |
2008 | -17.64% | -38.02% |
2007 | -28.46% | -62.95% |
2006 | -76.82% | -6.91% |
2005 | -82.52% | -12.09% |
2004 | -93.87% | |
2001 | -481.55% |
Company | Operating Margin | Operating Margin differencediff. | Country |
---|---|---|---|
![]() | -76.59% | -16.73% | ๐บ๐ธ USA |
![]() | -91.27% | -0.77% | ๐บ๐ธ USA |
![]() | -34.55% | -62.44% | ๐ฎ๐ช Ireland |
![]() | -8.61% | -90.64% | ๐บ๐ธ USA |
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.